OHTUVAYRE Trademark

Trademark Overview


On Thursday, March 14, 2024, a trademark application was filed for OHTUVAYRE with the United States Patent and Trademark Office. The USPTO has given the OHTUVAYRE trademark a serial number of 98450540. The federal status of this trademark filing is SUSPENSION LETTER - MAILED as of Wednesday, August 21, 2024. This trademark is owned by Verona Pharma PLC. The OHTUVAYRE trademark is filed in the Pharmaceutical Products, Computer & Software Services & Scientific Services, and Medical & Beauty Services & Agricultural Services categories with the following description:

Pharmaceutical preparations and substances for the treatment of respiratory conditions and disease, namely, chronic obstructive pulmonary disease, cystic fibrosis and asthma

Medical treatment services in the field of respiratory conditions and disease, namely, chronic obstructive pulmonary disease, cystic fibrosis and asthma; provision of medical information and services in the field of respiratory conditions and disease, namely, chronic obstructive pulmonary disease, cystic fibrosis and asthma

Scientific research for medical purposes, namely, the research and development of pharmaceutical preparations for the treatment of respiratory conditions and disease, in particular, chronic obstructive pulmonary disease, cystic fibrosis and asthma
ohtuvayre

General Information


Serial Number98450540
Word MarkOHTUVAYRE
Filing DateThursday, March 14, 2024
Status653 - SUSPENSION LETTER - MAILED
Status DateWednesday, August 21, 2024
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateNOT AVAILABLE

Trademark Statements


Goods and ServicesPharmaceutical preparations and substances for the treatment of respiratory conditions and disease, namely, chronic obstructive pulmonary disease, cystic fibrosis and asthma
Goods and ServicesMedical treatment services in the field of respiratory conditions and disease, namely, chronic obstructive pulmonary disease, cystic fibrosis and asthma; provision of medical information and services in the field of respiratory conditions and disease, namely, chronic obstructive pulmonary disease, cystic fibrosis and asthma
Goods and ServicesScientific research for medical purposes, namely, the research and development of pharmaceutical preparations for the treatment of respiratory conditions and disease, in particular, chronic obstructive pulmonary disease, cystic fibrosis and asthma

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateThursday, March 14, 2024
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateThursday, March 14, 2024
Primary Code042
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class044 - Medical services; veterinary services; hygienic and beauty care for human beings or animals; agriculture, horticulture and forestry services.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateTuesday, March 19, 2024
Primary Code044
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameVerona Pharma PLC
Party Type10 - Original Applicant
Legal Entity Type84 - NOT AVAILABLE
AddressCardiff CF101FS
GB

Trademark Events


Event DateEvent Description
Thursday, March 14, 2024NEW APPLICATION ENTERED
Tuesday, March 19, 2024TEAS AMENDMENT ENTERED BEFORE ATTORNEY ASSIGNED
Tuesday, March 19, 2024TEAS VOLUNTARY AMENDMENT RECEIVED
Wednesday, August 7, 2024NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Tuesday, August 20, 2024ASSIGNED TO EXAMINER
Wednesday, August 21, 2024NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Wednesday, August 21, 2024SUSPENSION LETTER WRITTEN
Wednesday, August 21, 2024LETTER OF SUSPENSION E-MAILED